Decoy Therapeutics

(NASDAQ) DCOY

Current Price$10.82

Market Cap$2.94M

Since IPO (2019)-100%

5 Year-100%

1 Year-97%

1 Month-31%

Decoy Therapeutics Financials at a Glance

Market Cap

$2.94M

Revenue (TTM)

$0.00

Net Income (TTM)

-$13.03M

EPS (TTM)

-$124.04

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$10.82

Volume

11,752,652.463

Open

$12.00

Price

$10.82

Volume

11,752,652.463

Open

$12.00

Previous Close

$5.52

Daily Range

$9.55 - $13.51

52-Week Range

$4.32 - $415.80

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$10.82

Volume

11,752,652.463

Open

$12.00

Previous Close

$5.52

Daily Range

$9.55 - $13.51

52-Week Range

$4.32 - $415.80

Estimated Earnings Date

Aug 11, 2026

DCOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Decoy Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Frederick E. Pierce, II

Website

decoytx.com

Headquarters

Cambridge, MA 02142, US

DCOY Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-395.42%

Return on Capital

-214.20%

Return on Assets

-154.73%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.94M

Shares Outstanding

532.00K

Volume

11.75M

Avg. Volume

18.77K

Financials (TTM)

Gross Profit

-$8.52M

Operating Income

-$13.18M

EBITDA

-$13.02M

Operating Cash Flow

-$6.53M

Capital Expenditure

$4.00

Free Cash Flow

-$6.53M

Cash & ST Invst.

$7.82M

Total Debt

$0.00

Decoy Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.94M

N/A

Market Cap/Employee

$1.47M

N/A

Employees

N/A

Net Income

-$2.22M

-30.1%

EBITDA

-$2.22M

-29.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$7.82M

+334.9%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.55%

N/A

Return on Invested Capital

-3.40%

N/A

Free Cash Flow

-$2.89M

-144.5%

Operating Cash Flow

-$2.89M

-144.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.02+4.12%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.44+1.44%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$2.63-4.55%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.25-28.00%

ENVBEnveric Biosciences, Inc.

ENVBEnveric Biosciences, Inc.$1.37-3.53%

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$3.14-7.92%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$5.35-6.10%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.65+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.59-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.35+0.15%

UPCUniverse Pharmaceuticals Inc

UPCUniverse Pharmaceuticals Inc$11.40+2.85%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.53-0.03%

MARAMara Holdings

MARAMara Holdings$14.37-0.01%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.84-0.03%

Questions About DCOY

What is the current price of Decoy Therapeutics?

Decoy Therapeutics is trading at $10.55 per share.

What is the 52-week range for Decoy Therapeutics?

Over the past 52 weeks, Decoy Therapeutics has traded between $4.32 and $415.80.

How much debt does Decoy Therapeutics have?

As of the most recent reporting period, Decoy Therapeutics reported total debt of $0.00.

How much cash does Decoy Therapeutics have on hand?

Decoy Therapeutics reported $7.82M in cash and cash equivalents in its most recent financial results.

What is Decoy Therapeutics’s dividend yield?

Decoy Therapeutics does not currently have a dividend yield.

Decoy Therapeutics

Decoy Therapeutics Financials at a Glance

DCOY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Decoy Therapeutics

DCOY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Decoy Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DCOY

What is the current price of Decoy Therapeutics?

What is the 52-week range for Decoy Therapeutics?

How much debt does Decoy Therapeutics have?

How much cash does Decoy Therapeutics have on hand?

What is Decoy Therapeutics’s dividend yield?

Premium Investing Services